Literature DB >> 23996016

Evaluation of a method for improving the detection of hepatocellular carcinoma.

Edgar Bendik1, Peter B Noël, Daniela Münzel, Alexander A Fingerle, Martin Henninger, Christian Markus, Alain Vlassenbroek, Ernst J Rummeny, Martin Dobritz.   

Abstract

OBJECTIVE: To improve the detection of liver lesions in patients with hepatocellular carcinoma (HCC) via an iodine contrast enhancement tool.
METHODS: Thirty-two patients with clinically proven HCCs underwent imaging with a three-phase protocol on a 256-slice MDCT. The contrast enhancement in the reconstructed slices was improved via a post-processing tool. Mean image noise was measured in four different regions: liver lesion, healthy liver, subcutaneous fat and bone. For each image set the image noise and contrast-to-noise ratio (CNR) were assessed. For subjective image assessment, four experienced radiologists evaluated the diagnostic quality.
RESULTS: While employing the post-processing algorithm, CNR between the liver lesion and healthy liver tissue improves significantly by a factor of 1.78 (CNRwithout vC = 2.30 ± 1.92/CNRwith vC = 4.11 ± 3.05) (P* = 0.01). All results could be achieved without a strengthening of artefacts; mean HU values of subcutaneous fat and bone did not significantly change. Subjective image analysis illustrated a significant improvement when employing post-processing for clinically relevant criteria such as diagnostic confidence.
CONCLUSION: With post-processing we see a significantly improved detection of arterial uptake in hepatic lesions compared with non-processed data. The improvement in CNR was confirmed by subjective image assessment for small lesions and for lesions with limited uptake. KEY POINTS: • Enhancement with iodine-based contrast agents is an essential part of CT. • A new post-processing tool significantly improves the diagnostics of hepatocellular carcinoma. • It also improves detection of small lesions with limited iodine uptake.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996016     DOI: 10.1007/s00330-013-3006-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

Review 1.  Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.

Authors:  Takamichi Murakami; Masatoshi Hori; Tonsok Kim; Shuji Kawata; Hisashi Abe; Hironobe Nakamura
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

2.  Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT.

Authors:  Carlos Valls; Mònica Cos; Juan Figueras; Eduard Andía; Emilio Ramos; Anna Sánchez; Teresa Serrano; Jaume Torras
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959

3.  A method for improving iodine contrast enhancement in abdominal computed tomography: experimental study in a pig model.

Authors:  Peter B Noël; Edgar Bendik; Daniela Münzel; Armin Schneider; Liran Goshen; Asher Gringauz; Yechiel Lamash; Alain Vlassenbroek; Alexander A Fingerle; Ernst J Rummeny; Martin Dobritz
Journal:  Eur Radiol       Date:  2012-10-19       Impact factor: 5.315

4.  Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT.

Authors:  T Murakami; T Kim; M Takamura; M Hori; S Takahashi; M P Federle; K Tsuda; K Osuga; S Kawata; H Nakamura; M Kudo
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

5.  Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Authors:  Seong Hyun Kim; Dongil Choi; Seung Hoon Kim; Jae Hoon Lim; Won Jae Lee; Min Ju Kim; Hyo K Lim; Soon Jin Lee
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 6.  Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions.

Authors:  M Kudo
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

7.  Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.

Authors:  Kazuo Awai; Koichi Takada; Hiromitsu Onishi; Shinichi Hori
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

Review 8.  Contrast-induced nephropathy.

Authors:  G T C Wong; M G Irwin
Journal:  Br J Anaesth       Date:  2007-08-06       Impact factor: 9.166

9.  Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.

Authors:  Daniele Marin; Michele Di Martino; Antonino Guerrisi; Gianmaria De Filippis; Massimo Rossi; Stefano Ginanni Corradini; Raffaele Masciangelo; Carlo Catalano; Roberto Passariello
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  2 in total

1.  Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Michael A Fischer; Nikolaos Kartalis; Aristeidis Grigoriadis; Louiza Loizou; Per Stål; Bertil Leidner; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

2.  Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching study.

Authors:  Hao Hu; Zhenhua Duan; Xiaoran Long; Yancu Hertzanu; Xiaoqiang Tong; Xiaoquan Xu; Haibin Shi; Sheng Liu; Zhengqiang Yang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.